Form 4: Health Catalyst CEO Daniel D. Burton Acquires 26,200 Shares of Common Stock
SEC Form 4 Filing
Daniel D. Burton, CEO of Health Catalyst, Inc., reports the acquisition of 26,200 shares of common stock at a price of $7.8063 per share on February 27, 2024.
Summary
- On February 27, 2024, Daniel D. Burton, the CEO of Health Catalyst, Inc. (HCAT), acquired 26,200 shares of common stock.
- The purchase price was $7.8063 per share.
- Following the transaction, Burton directly owns 1,172,623 shares of Health Catalyst common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock acquisition by the CEO. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and directors, allowing investors to monitor their investment decisions.
Stakeholder Impact
- The acquisition of shares by the CEO could be perceived positively by shareholders, signaling confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of transaction: CEO Daniel D. Burton acquired 26,200 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.